Skip to main content
Cardiac Marker

NT-proBNP and BNP Explained

What these heart-stretch hormones measure, why a low result is the most useful part of the test, and why the same number means something different at 40 and at 80.
Analyse My Results Free

Free to use, no credit card, works with any Australian lab

Illustration of a heart releasing natriuretic peptide hormones, relevant to the NT-proBNP and BNP blood test

· · Reviewed against the sources listed at the end of this page.

The Quick Answer

NT-proBNP and BNP are hormone fragments released by heart muscle cells when they are stretched by rising pressure inside the heart, most often because the heart is struggling to fill or pump normally. Both come from the same precursor molecule and are released together in equal amounts, but NT-proBNP is the one more commonly measured in Australia.

The test’s main job is to rule heart failure out, not in. If you have breathlessness or swollen legs and your NT-proBNP comes back low, heart failure becomes very unlikely, and your GP can look elsewhere for the cause with confidence, often avoiding an urgent echocardiogram or hospital admission. A high result is far less specific and needs an echocardiogram and clinical assessment before heart failure is actually diagnosed.

There is no single normal number. NT-proBNP rises naturally with age even in a healthy heart, so a result that is unremarkable at 80 could be significant at 40. This is why doctors use age-stratified thresholds rather than one universal cut-off, covered in detail below.

Typical rule-out threshold quoted by Australian pathology laboratories, non-urgent symptoms:

Heart failure unlikely: below approx. 125 pg/mL
Needs further assessment: above this level

NT-proBNP does not have one nationally harmonised reference interval, and acute settings use different, age-banded cut-offs from chronic outpatient settings. Always check the range and any comment printed on your own report.

What NT-proBNP and BNP Actually Measure

Heart muscle cells, mainly in the ventricles, produce a precursor molecule called proBNP. When the heart wall is stretched by rising filling pressure, an enzyme splits proBNP into two pieces released together in a fixed one-to-one ratio: BNP, the biologically active hormone that helps the body offload excess fluid and sodium and relax blood vessels, and NT-proBNP, the inactive leftover fragment that has no direct hormonal effect but is easier to measure reliably.

Because more stretch means more proBNP is cut up and released, the blood level of both fragments rises roughly in proportion to how hard the heart is straining to fill or pump against elevated pressure. Neither test is specific to one single cause of that strain, which is why the result is always read alongside the wider clinical picture.

Two Common Reasons for Testing

Breathlessness (dyspnoea)

New, worsening, or unexplained shortness of breath, whether on exertion, at rest, or waking you at night, is the single most common reason NT-proBNP is ordered. A low result makes heart failure very unlikely and points your GP towards lung disease, anaemia, deconditioning, or another cause instead.

Swollen legs or ankles (peripheral oedema)

Fluid retention in the lower legs can come from heart failure, but also from venous disease, some medicines, kidney or liver problems, or simply prolonged sitting or standing. NT-proBNP helps work out how likely a heart cause is before further tests are arranged.

BNP versus NT-proBNP

Where it comes from

BNP: The active hormone fragment, cleaved from proBNP at the same time as NT-proBNP

NT-proBNP: The inactive leftover fragment, cleaved from the same proBNP molecule in a fixed one-to-one ratio with BNP

Stability in the sample

BNP: Breaks down faster once the blood is drawn, so timing and handling of the sample matter more

NT-proBNP: More stable at room temperature during transport to the laboratory, which suits the centralised Australian pathology model

Half-life in the blood

BNP: Roughly 20 minutes

NT-proBNP: Roughly 60 to 120 minutes, giving a steadier, less minute-to-minute reading

Effect of sacubitril-valsartan (Entresto)

BNP: Rises, because this medicine blocks the enzyme (neprilysin) that normally breaks BNP down

NT-proBNP: Not affected by this mechanism, so it continues to reflect true heart status in people taking the medicine

Typical use in Australia

BNP: Less commonly used, though still available at some laboratories

NT-proBNP: The more commonly used of the two, for the stability and treatment-interaction reasons above

The combination of better sample stability and unaffected results in people taking sacubitril-valsartan is why NT-proBNP is the more commonly requested test in Australian general practice and cardiology.

Why One Cut-Off Does Not Work for Everyone

NT-proBNP rises naturally with age, even in people with a perfectly healthy heart. A single universal threshold would either miss heart failure in younger people or over-diagnose it in the elderly, so doctors use different thresholds depending on how urgent the symptoms are and, in the acute setting, the person’s age.

Any age, gradual or non-urgent symptoms

Below approximately 125 pg/mL (14.8 pmol/L)

Above this level, further assessment is generally needed

Used in general practice and outpatient settings for chronic, gradually worsening breathlessness. This single cut-off applies regardless of age and is the threshold most GP pathology reports quote as the reference interval.

Any age, acute or sudden symptoms

Below approximately 300 pg/mL

Above this level, heart failure is possible and age-banded cut-offs are then applied

Used in emergency departments for sudden, severe breathlessness. A single low threshold applies across all ages to rule heart failure out quickly, before the higher, age-specific cut-offs below are used to help rule it in.

Under 50 years, acute symptoms

See the acute rule-out threshold above

Above approximately 450 pg/mL, acute heart failure becomes likely

A younger heart typically produces less NT-proBNP for the same degree of stretch, so a lower threshold is used to flag likely heart failure in this age group.

50 to 75 years, acute symptoms

See the acute rule-out threshold above

Above approximately 900 pg/mL, acute heart failure becomes likely

The middle age band uses a higher cut-off than under-50s, reflecting the normal age-related rise in baseline NT-proBNP even without heart disease.

Over 75 years, acute symptoms

See the acute rule-out threshold above

Above approximately 1800 pg/mL, acute heart failure becomes likely

Older adults have the highest normal baseline NT-proBNP of any age group, so a single universal cut-off would either miss heart failure in the young or over-diagnose it in the elderly. This is why one number cannot work for everyone.

Already had your NT-proBNP or BNP tested?

Upload your pathology PDF and SmarterBlood explains where your specific result sits against the age-based thresholds, in plain English, alongside every other marker on your report.

Upload Your Results Free

What Else Raises NT-proBNP Besides Heart Failure

A raised NT-proBNP is not the same as a heart failure diagnosis. These conditions raise it through their own, separate mechanisms, and your GP will usually check for them before attributing a high result to heart failure alone.

Advancing age

Normal age-related stiffening of the heart muscle and blood vessels gradually raises baseline wall stress

This is why age-banded cut-offs exist rather than one universal threshold. A result that would be concerning in a 40-year-old can be an unremarkable finding in an 80-year-old.

Atrial fibrillation

The irregular, often rapid heart rhythm stretches the upper heart chambers, which release natriuretic peptides independently of the pumping chambers below

NT-proBNP is often raised in atrial fibrillation even when heart pumping function is entirely normal, so a raised result in someone with known atrial fibrillation needs careful interpretation alongside an echocardiogram.

Chronic kidney disease

The kidneys are a major clearance route for NT-proBNP, so reduced kidney function lets it accumulate in the blood

This effect can be substantial, and reference ranges shift as eGFR falls. Your GP will always interpret NT-proBNP alongside your kidney function, since a raised result in someone with significant chronic kidney disease may reflect reduced clearance rather than heart failure.

Pulmonary embolism

A clot blocking part of the lung circulation suddenly raises pressure in the right side of the heart, stretching the right ventricle

A raised NT-proBNP in someone with sudden breathlessness and chest pain can be an early clue to right heart strain from pulmonary embolism rather than left heart failure, and is one of several markers used in risk-stratifying a confirmed embolism.

Pulmonary hypertension

Chronically elevated pressure in the lung arteries places sustained strain on the right ventricle

NT-proBNP is used both to help suspect pulmonary hypertension and, once diagnosed, to help track disease severity and response to treatment over time.

Sepsis and other serious acute illness

Severe systemic illness places direct strain on the heart and can also transiently impair its pumping function

NT-proBNP is frequently and sometimes markedly raised during sepsis or critical illness even without any pre-existing heart disease, and it is not a reliable heart failure marker in this setting until the acute illness has settled.

Significant anaemia

A low haemoglobin forces the heart to work harder and pump more blood to deliver the same amount of oxygen, increasing wall stress

Checking a full blood count alongside NT-proBNP is routine practice, since correcting significant anaemia can improve breathlessness and lower NT-proBNP without any change in underlying heart function.

Severe heart valve disease

Conditions such as significant aortic stenosis or mitral regurgitation directly increase pressure or volume load on the heart chambers

A raised NT-proBNP in someone with a known heart murmur or valve disease can reflect the valve problem itself rather than a separate heart failure process, which an echocardiogram will clarify.

What Lowers NT-proBNP, and Why That Can Be Misleading

Just as some conditions push NT-proBNP up for reasons unrelated to heart failure, two common situations can push it down, or keep it looking artificially reassuring, even when significant heart failure is present.

Obesity

Obesity markedly suppresses NT-proBNP, likely through how fat tissue clears and processes natriuretic peptides. A person carrying significant excess weight can have a genuinely lower result than a lean person with the same degree of heart strain. This means a normal-looking result in someone who is obese and breathless should not be treated as fully reassuring on its own, and clinical judgement, and often an echocardiogram, still matters.

Sacubitril-valsartan (Entresto)

This heart failure medicine blocks the enzyme neprilysin, which normally breaks down BNP, so it actually raises measured BNP even when the heart is improving. NT-proBNP is cleared through a different route that this medicine does not block, so it is not artificially raised by treatment and remains the more trustworthy of the two tests for anyone taking this medicine. Mixing up BNP and NT-proBNP results in this situation is a well-known source of confusion.

Want to see how NT-proBNP fits with troponin and your other heart markers?

Read the Cardiac Biomarkers Guide

Using Serial NT-proBNP to Track Treatment

In someone with confirmed heart failure, repeating NT-proBNP over weeks to months is a useful, if imperfect, way to gauge how well treatment is working. A substantially falling trend alongside improving symptoms generally supports that diuretics, an ACE inhibitor or ARB, sacubitril-valsartan, a beta blocker, or a mineralocorticoid receptor antagonist are having the intended effect. A rising trend despite treatment can flag early decompensation before symptoms become obvious, sometimes prompting a medicine adjustment before a hospital admission becomes necessary.

NT-proBNP naturally varies by roughly 30 to 50 percent from test to test even when the heart is entirely stable, simply from normal day-to-day biological variation. Because of this, doctors generally look for a clearly meaningful change over time rather than reacting to small week-to-week movements, and a single result is never read in isolation from your symptoms, weight, and clinical examination.

Getting Tested in Australia and Medicare

NT-proBNP and BNP are available at all major Australian pathology providers and use a standard blood draw, with no fasting required. They are frequently ordered as a private, out-of-pocket test in general practice, since they are not part of the standard Medicare-rebated pathology schedule for routine investigation of breathlessness.

A Medicare rebate can apply in some circumstances, such as assessment of acute, unexplained breathlessness in a hospital or emergency department setting, subject to the current Medicare Benefits Schedule rules. Ask your GP or the pathology provider whether a rebate is likely to apply before the sample is collected, and expect a modest out-of-pocket cost if it does not.

What Your GP Does Next

1
Order NT-proBNP alongside routine bloods

A full blood count, kidney function (eGFR), electrolytes, liver function, and thyroid function are usually checked at the same time, since anaemia, chronic kidney disease, and thyroid disease can all raise NT-proBNP or mimic heart failure symptoms on their own.

2
12-lead ECG

Looks for atrial fibrillation, signs of an enlarged heart chamber, or evidence of a previous or ongoing heart attack, all of which help explain a raised result and guide how urgently further testing is needed.

3
Chest X-ray

Checks for fluid in or around the lungs, an enlarged heart shadow, and alternative explanations for breathlessness such as pneumonia, a pleural effusion, or lung disease.

4
Echocardiogram

The key confirmatory test once NT-proBNP is raised or the picture is ambiguous. It directly assesses pumping function (ejection fraction), how well the heart relaxes and fills (diastolic function), and the heart valves, and is what actually diagnoses heart failure rather than the blood test alone.

5
Iron studies

Iron deficiency is a very common and treatable coexisting problem in people with confirmed heart failure, and correcting it improves symptoms and exercise capacity independently of standard heart failure medicines.

6
Review kidney function alongside the result

Because reduced kidney function raises NT-proBNP through slower clearance, your eGFR is read together with the result rather than the NT-proBNP being interpreted in isolation.

7
Cardiology referral

Arranged once heart failure is confirmed on echocardiogram, or when the NT-proBNP result and clinical picture remain unclear despite the steps above. A cardiologist will also guide long-term medicine choices and monitoring.

When to Seek Urgent Care

Sudden, severe breathlessness at rest, or breathlessness that wakes you from sleep

This can indicate acute pulmonary oedema, a medical emergency. Call 000 rather than waiting for a blood test result.

Breathlessness with chest pain, palpitations, or fainting

These combined symptoms need urgent assessment to exclude a heart attack, a dangerous arrhythmia, or a large pulmonary embolism, not a routine follow-up appointment.

Coughing up pink or frothy sputum

A classic sign of fluid backing up into the lungs (acute pulmonary oedema). This is a medical emergency; call 000.

Rapid weight gain of more than 2 kilograms over two to three days, or fast-worsening leg or ankle swelling

This usually reflects fluid retention and can precede a significant deterioration in known heart failure. Contact your GP or heart failure service the same day, do not wait for a scheduled review.

Known heart failure with worsening breathlessness despite taking your usual medicines correctly

This pattern can indicate that your current treatment is no longer adequately controlling your condition and needs urgent review, possibly including a same-day NT-proBNP recheck.

Sources and reference ranges

Adult reference ranges on this page follow the AACB and RCPA harmonised reference intervals unless stated otherwise; the range printed on your own report always takes precedence because laboratories differ.

NT-proBNP and BNP Explained, Frequently Asked Questions

What is NT-proBNP and why would my doctor order it?

NT-proBNP is a hormone fragment released by heart muscle cells when they are stretched by rising pressure inside the heart chambers, most often because the heart is struggling to pump or fill normally. Your GP usually orders it when you have breathlessness, swollen ankles or legs, or unexplained fatigue, and they want to work out whether heart failure is a likely explanation. Its main strength is ruling heart failure out: a low result makes heart failure very unlikely and can avoid the need for an urgent echocardiogram or hospital admission.

What is a normal NT-proBNP level for my age?

There is no single normal number, because NT-proBNP rises naturally with age even in a healthy heart. As a general guide for someone with gradual, non-urgent symptoms, a result below roughly 125 pg/mL makes heart failure unlikely at any age. In an acute setting such as an emergency department, doctors use age-banded cut-offs instead, roughly 450 pg/mL under 50, 900 pg/mL from 50 to 75, and 1800 pg/mL over 75, above which heart failure becomes more likely. Always read the reference interval and any interpretive comment printed on your own report, since methods vary slightly between Australian laboratories.

Can NT-proBNP rule out heart failure on its own?

A low NT-proBNP is one of the most reliable rule-out results in cardiology. Below the relevant cut-off, the chance that breathlessness or swelling is being caused by heart failure is very low, and doctors can usually look elsewhere for the cause with confidence. It is far less reliable at ruling heart failure in, since many other conditions raise NT-proBNP too. A high result needs an echocardiogram and clinical assessment before heart failure is diagnosed, not a high NT-proBNP alone.

What causes a high NT-proBNP besides heart failure?

Several conditions raise NT-proBNP independently of heart failure, which is why the result is always interpreted alongside the clinical picture. Common contributors include simply being older, atrial fibrillation, chronic kidney disease (which can raise it substantially because the kidneys normally help clear it), pulmonary embolism, pulmonary hypertension, sepsis and other serious acute illness, significant anaemia, and severe heart valve disease. Your GP will usually check kidney function and look for these alternative explanations before concluding a raised result is due to heart failure.

Does obesity affect NT-proBNP results?

Yes, and in the opposite direction to what people often expect. Obesity markedly suppresses NT-proBNP, so a person with a higher body weight can have a genuinely lower result than a lean person with the same degree of heart failure. This is thought to relate to how fat tissue clears and processes natriuretic peptides. Because of this, a normal-looking NT-proBNP in someone who is significantly overweight and breathless should not be treated as fully reassuring, and your GP may still proceed to an echocardiogram if the clinical suspicion of heart failure is high.

What is the difference between BNP and NT-proBNP?

Both come from the same precursor molecule, proBNP, which is split into two pieces when it is released: the active hormone BNP, and the inactive leftover fragment NT-proBNP. BNP is cleared quickly and is less stable once the blood sample is taken, while NT-proBNP has a longer half-life and holds up better during transport to the laboratory, which is a major reason it is the more commonly used of the two in Australian pathology. The two also behave differently in people taking the heart failure medicine sacubitril-valsartan, which is another reason NT-proBNP is generally preferred.

Does sacubitril-valsartan (Entresto) affect my NT-proBNP result?

Sacubitril-valsartan (often known by the brand name Entresto) works partly by blocking the enzyme that normally breaks BNP down, so it raises measured BNP levels even when heart failure is well controlled or improving. NT-proBNP is cleared by a different route that this medicine does not block, so it is not artificially raised by treatment and continues to reflect your heart's true filling pressures. This is the main reason doctors track NT-proBNP rather than BNP in people taking this medicine, and why the two tests should not be compared directly in this situation.

Is the NT-proBNP test covered by Medicare in Australia?

NT-proBNP and BNP are frequently ordered as a private, out-of-pocket pathology test in general practice, since they are not part of the standard Medicare-rebated pathology schedule for routine investigation. A rebate can apply in some circumstances, such as assessment of acute unexplained breathlessness in a hospital or emergency department setting, subject to the current Medicare Benefits Schedule rules. Ask your GP or the pathology provider whether a rebate is likely to apply before the sample is collected, and expect a modest out-of-pocket cost if it does not.

Can NT-proBNP be used to see if my heart failure treatment is working?

Yes, serial NT-proBNP measurements over weeks to months are a useful, if imperfect, way to track response to heart failure treatment. A substantially falling trend alongside improving symptoms generally supports that diuretics, ACE inhibitors, ARBs, sacubitril-valsartan, beta blockers, or other heart failure medicines are working. A rising trend despite treatment can flag early decompensation before symptoms become obvious. Because NT-proBNP naturally varies by up to 30 to 50 percent from test to test even when the heart is stable, doctors generally look for a clearly meaningful change rather than reacting to small week-to-week movements.


Got an NT-proBNP or BNP Result?

Upload your pathology PDF and SmarterBlood's AI explains your NT-proBNP alongside troponin and every other marker on your report, in plain English, with Australian reference ranges, so you understand what your result means before your next appointment.

This page provides general educational information about the NT-proBNP and BNP blood tests and how they are used to assess suspected heart failure. It is not a substitute for professional medical advice, diagnosis, or treatment, and it does not diagnose any condition. Always discuss your own NT-proBNP or BNP result with your GP or cardiologist, who can interpret it in the context of your full medical history and, if needed, an echocardiogram. SmarterBlood does not provide medical care.